HomeSYRS • NASDAQ
add
Syros Pharmaceuticals Inc
Previous close
$5.11
Day range
$4.72 - $5.06
Year range
$2.09 - $8.17
Market cap
124.86M USD
Avg Volume
230.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 386.00K | 151.19% |
Operating expense | 5.89M | -19.66% |
Net income | -64.38M | -1,248.64% |
Net profit margin | -16.68K | -2,734.37% |
Earnings per share | -2.22 | -1,204.41% |
EBITDA | -26.65M | 24.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 139.53M | -31.03% |
Total assets | 168.17M | -31.21% |
Total liabilities | 151.51M | 29.77% |
Total equity | 16.66M | — |
Shares outstanding | 26.45M | — |
Price to book | 8.11 | — |
Return on assets | -42.73% | — |
Return on capital | -76.07% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -64.38M | -1,248.64% |
Cash from operations | -18.56M | 40.28% |
Cash from investing | 1.52M | -95.97% |
Cash from financing | 43.38M | 505.31% |
Net change in cash | 26.34M | 747.97% |
Free cash flow | -7.48M | 74.21% |
About
Founded
2011
Website
Employees
68
